Vemurafenib blocks cell proliferation, induces cellular stress and senescence of melanoma cells via inhibition of the B-Raf/MEK/ERK pathway (Haferkamp et al, 2013; Peng et al, 2017; Su et al, 2020). Here, BRAF is linked to melanoma.